Trials / Unknown
UnknownNCT01043679
Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar Mania
A Randomized Open-label Active-controlled Study to Evaluate the Efficacy and Safety of Utapine Versus Seroquel in Patients With Bipolar Mania
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Taichung Veterans General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The goal of this research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in bipolar I disorder patients.
Detailed description
Utapine and Serquel belong to anti-bipolar medication family, both are approved by DOH (Department of Health, Taiwan), both has same ingredient but different manufacture. From clinical trial reports, both has excellent effectiveness and safety. The goal of this research is to evaluate the safety as well as effectiveness of Utapine and Seroquel in bipolar I disorder patients for different ingredient and different manufacture.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Utapine | Efficacy and Safety of Utapine |
| DRUG | Seroquel | Efficacy and Safety of Seroquel |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-01-07
- Last updated
- 2010-01-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01043679. Inclusion in this directory is not an endorsement.